SCHEMBL25531121

SCHEMBL25531121

CCN(CC1CCC1)C(C)Cc1ccc(C(C)(C)C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 2/20 0.41
▸ TSHR P16473 2/20 0.40
▸ TP53 P04637 1/20 0.40
▸ SIGMAR1 Q99720 3/20 0.38
▸ EBP Q15125 1/20 0.38
▸ ACACB O00763 4/20 0.37
▸ ADRA2A P08913 1/20 0.34
▸ ADRA2B P18089 1/20 0.34
▸ ADRA2C P18825 1/20 0.34
▸ ADRA1D P25100 1/20 0.34
▸ HTR1D P28221 1/20 0.34
▸ HTR1B P28222 1/20 0.34
▸ ADRA1A P35348 1/20 0.34
▸ ADRA1B P35368 1/20 0.34
▸ TRPV1 Q8NER1 1/20 0.32
▸ COPS5 Q92905 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ KCNH2 Q12809 1/20 0.31
▸ CYP19A1 P11511 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25531110 0.85 SIGMAR1 (0.40) CYP2D6TSHRTP53SIGMAR1EBP
SCHEMBL25541888 0.85 KCNH2 (0.41) CYP2D6TSHRTP53SIGMAR1EBP
SCHEMBL25531105 0.85 SIGMAR1 (0.40) CYP2D6TSHRTP53SIGMAR1EBP
SCHEMBL25541880 0.84 TP53 (0.38) CYP2D6TSHRTP53SIGMAR1EBP
SCHEMBL25541876 0.84 TP53 (0.38) CYP2D6TSHRTP53SIGMAR1EBP
SCHEMBL25531120 0.83 TP53 (0.42) TSHRTP53SIGMAR1EBPACACB
SCHEMBL25530541 0.77 TP53 (0.46) TSHRTP53SIGMAR1EBPACACB
SCHEMBL23482025 0.75 OPRK1 (0.50) CYP2D6TSHRSIGMAR1ADRA2AADRA2B
SCHEMBL25531037 0.74 HRH3 (0.41) CYP2D6ADRA2AADRA2BADRA2CADRA1D
SCHEMBL4682403 0.72 MCHR1 (0.43) CYP2D6TSHRKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159491-A1 Antimicrobial Compounds and Methods NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159491-A1 Antimicrobial Compounds and Methods MPO, NISCH, RPN2 CYP2D6 1521/4885TSHR 4733/4885TP53 4099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback